ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Radiolabelled ADME Studies Market Research Report 2024
Published Date: July 2024
|
Report Code: QYRE-Auto-26S17325
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Radiolabelled ADME Studies Market Research Report 2024
BUY CHAPTERS

Global Radiolabelled ADME Studies Market Research Report 2024

Code: QYRE-Auto-26S17325
Report
July 2024
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Companies
Charles River
Eurofins Scientific
Evotec AG
LabCorp
SEKISUI Medical
XenoTech (BioIVT)
QPS
Bioduro-Sundia
Quotient Sciences
Chelatec
HMR
Nuvisan
Fluorizon
WuXi AppTec
Pharmaron
Innostar
Medicilon
Frontage
Value Pharmaceutical
New Radiomedicine Technology

Radiolabelled ADME Studies Market

Radiolabelled ADME studies utilize radiolabelled (radioactive) versions of a drug to track its journey through the body. The radioactive label allows for precise detection and quantification of the drug and its metabolites, facilitating a comprehensive understanding of its pharmacokinetic profile.
The global Radiolabelled ADME Studies market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Radiolabelled ADME Studies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Radiolabelled ADME Studies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Radiolabelled ADME Studies in Biopharmaceutical Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Radiolabelled ADME Studies include Charles River, Eurofins Scientific, Evotec, Labcorp, Sekisui Medical, XenoTech (BioIVT), QPS, BioDuro-Sundia, Quotient Sciences, Chelatec, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Radiolabelled ADME Studies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radiolabelled ADME Studies.
The Radiolabelled ADME Studies market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Radiolabelled ADME Studies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Radiolabelled ADME Studies companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Radiolabelled ADME Studies Market Report

Report Metric Details
Report Name Radiolabelled ADME Studies Market
Segment by Type
  • C-14
  • H-3
  • Others
Segment by Application
  • Biopharmaceutical Companies
  • Government and Academic Institutes
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Charles River, Eurofins Scientific, Evotec, Labcorp, Sekisui Medical, XenoTech (BioIVT), QPS, BioDuro-Sundia, Quotient Sciences, Chelatec, HMR, Nuvisan, Fluorizon, WuXi AppTec, Pharmaron, InnoStar, Medicilon, Frontage, Value Pharmaceutical, New Radiomedicine Technology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Radiolabelled ADME Studies company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Radiolabelled ADME Studies Market report?

Ans: The main players in the Radiolabelled ADME Studies Market are Charles River, Eurofins Scientific, Evotec, Labcorp, Sekisui Medical, XenoTech (BioIVT), QPS, BioDuro-Sundia, Quotient Sciences, Chelatec, HMR, Nuvisan, Fluorizon, WuXi AppTec, Pharmaron, InnoStar, Medicilon, Frontage, Value Pharmaceutical, New Radiomedicine Technology

What are the Application segmentation covered in the Radiolabelled ADME Studies Market report?

Ans: The Applications covered in the Radiolabelled ADME Studies Market report are Biopharmaceutical Companies, Government and Academic Institutes, Others

What are the Type segmentation covered in the Radiolabelled ADME Studies Market report?

Ans: The Types covered in the Radiolabelled ADME Studies Market report are C-14, H-3, Others

Recommended Reports

ADME and PK Services

Radiation and Diagnostics

Biopharma and Test Kits

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Radiolabelled ADME Studies Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 C-14
1.2.3 H-3
1.2.4 Others
1.3 Market by Application
1.3.1 Global Radiolabelled ADME Studies Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biopharmaceutical Companies
1.3.3 Government and Academic Institutes
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Radiolabelled ADME Studies Market Perspective (2019-2030)
2.2 Global Radiolabelled ADME Studies Growth Trends by Region
2.2.1 Global Radiolabelled ADME Studies Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Radiolabelled ADME Studies Historic Market Size by Region (2019-2024)
2.2.3 Radiolabelled ADME Studies Forecasted Market Size by Region (2025-2030)
2.3 Radiolabelled ADME Studies Market Dynamics
2.3.1 Radiolabelled ADME Studies Industry Trends
2.3.2 Radiolabelled ADME Studies Market Drivers
2.3.3 Radiolabelled ADME Studies Market Challenges
2.3.4 Radiolabelled ADME Studies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Radiolabelled ADME Studies Players by Revenue
3.1.1 Global Top Radiolabelled ADME Studies Players by Revenue (2019-2024)
3.1.2 Global Radiolabelled ADME Studies Revenue Market Share by Players (2019-2024)
3.2 Global Radiolabelled ADME Studies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Radiolabelled ADME Studies Revenue
3.4 Global Radiolabelled ADME Studies Market Concentration Ratio
3.4.1 Global Radiolabelled ADME Studies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Radiolabelled ADME Studies Revenue in 2023
3.5 Global Key Players of Radiolabelled ADME Studies Head office and Area Served
3.6 Global Key Players of Radiolabelled ADME Studies, Product and Application
3.7 Global Key Players of Radiolabelled ADME Studies, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Radiolabelled ADME Studies Breakdown Data by Type
4.1 Global Radiolabelled ADME Studies Historic Market Size by Type (2019-2024)
4.2 Global Radiolabelled ADME Studies Forecasted Market Size by Type (2025-2030)
5 Radiolabelled ADME Studies Breakdown Data by Application
5.1 Global Radiolabelled ADME Studies Historic Market Size by Application (2019-2024)
5.2 Global Radiolabelled ADME Studies Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Radiolabelled ADME Studies Market Size (2019-2030)
6.2 North America Radiolabelled ADME Studies Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Radiolabelled ADME Studies Market Size by Country (2019-2024)
6.4 North America Radiolabelled ADME Studies Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Radiolabelled ADME Studies Market Size (2019-2030)
7.2 Europe Radiolabelled ADME Studies Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Radiolabelled ADME Studies Market Size by Country (2019-2024)
7.4 Europe Radiolabelled ADME Studies Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Radiolabelled ADME Studies Market Size (2019-2030)
8.2 Asia-Pacific Radiolabelled ADME Studies Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Radiolabelled ADME Studies Market Size by Region (2019-2024)
8.4 Asia-Pacific Radiolabelled ADME Studies Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Radiolabelled ADME Studies Market Size (2019-2030)
9.2 Latin America Radiolabelled ADME Studies Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Radiolabelled ADME Studies Market Size by Country (2019-2024)
9.4 Latin America Radiolabelled ADME Studies Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Radiolabelled ADME Studies Market Size (2019-2030)
10.2 Middle East & Africa Radiolabelled ADME Studies Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Radiolabelled ADME Studies Market Size by Country (2019-2024)
10.4 Middle East & Africa Radiolabelled ADME Studies Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Details
11.1.2 Charles River Business Overview
11.1.3 Charles River Radiolabelled ADME Studies Introduction
11.1.4 Charles River Revenue in Radiolabelled ADME Studies Business (2019-2024)
11.1.5 Charles River Recent Development
11.2 Eurofins Scientific
11.2.1 Eurofins Scientific Company Details
11.2.2 Eurofins Scientific Business Overview
11.2.3 Eurofins Scientific Radiolabelled ADME Studies Introduction
11.2.4 Eurofins Scientific Revenue in Radiolabelled ADME Studies Business (2019-2024)
11.2.5 Eurofins Scientific Recent Development
11.3 Evotec
11.3.1 Evotec Company Details
11.3.2 Evotec Business Overview
11.3.3 Evotec Radiolabelled ADME Studies Introduction
11.3.4 Evotec Revenue in Radiolabelled ADME Studies Business (2019-2024)
11.3.5 Evotec Recent Development
11.4 Labcorp
11.4.1 Labcorp Company Details
11.4.2 Labcorp Business Overview
11.4.3 Labcorp Radiolabelled ADME Studies Introduction
11.4.4 Labcorp Revenue in Radiolabelled ADME Studies Business (2019-2024)
11.4.5 Labcorp Recent Development
11.5 Sekisui Medical
11.5.1 Sekisui Medical Company Details
11.5.2 Sekisui Medical Business Overview
11.5.3 Sekisui Medical Radiolabelled ADME Studies Introduction
11.5.4 Sekisui Medical Revenue in Radiolabelled ADME Studies Business (2019-2024)
11.5.5 Sekisui Medical Recent Development
11.6 XenoTech (BioIVT)
11.6.1 XenoTech (BioIVT) Company Details
11.6.2 XenoTech (BioIVT) Business Overview
11.6.3 XenoTech (BioIVT) Radiolabelled ADME Studies Introduction
11.6.4 XenoTech (BioIVT) Revenue in Radiolabelled ADME Studies Business (2019-2024)
11.6.5 XenoTech (BioIVT) Recent Development
11.7 QPS
11.7.1 QPS Company Details
11.7.2 QPS Business Overview
11.7.3 QPS Radiolabelled ADME Studies Introduction
11.7.4 QPS Revenue in Radiolabelled ADME Studies Business (2019-2024)
11.7.5 QPS Recent Development
11.8 BioDuro-Sundia
11.8.1 BioDuro-Sundia Company Details
11.8.2 BioDuro-Sundia Business Overview
11.8.3 BioDuro-Sundia Radiolabelled ADME Studies Introduction
11.8.4 BioDuro-Sundia Revenue in Radiolabelled ADME Studies Business (2019-2024)
11.8.5 BioDuro-Sundia Recent Development
11.9 Quotient Sciences
11.9.1 Quotient Sciences Company Details
11.9.2 Quotient Sciences Business Overview
11.9.3 Quotient Sciences Radiolabelled ADME Studies Introduction
11.9.4 Quotient Sciences Revenue in Radiolabelled ADME Studies Business (2019-2024)
11.9.5 Quotient Sciences Recent Development
11.10 Chelatec
11.10.1 Chelatec Company Details
11.10.2 Chelatec Business Overview
11.10.3 Chelatec Radiolabelled ADME Studies Introduction
11.10.4 Chelatec Revenue in Radiolabelled ADME Studies Business (2019-2024)
11.10.5 Chelatec Recent Development
11.11 HMR
11.11.1 HMR Company Details
11.11.2 HMR Business Overview
11.11.3 HMR Radiolabelled ADME Studies Introduction
11.11.4 HMR Revenue in Radiolabelled ADME Studies Business (2019-2024)
11.11.5 HMR Recent Development
11.12 Nuvisan
11.12.1 Nuvisan Company Details
11.12.2 Nuvisan Business Overview
11.12.3 Nuvisan Radiolabelled ADME Studies Introduction
11.12.4 Nuvisan Revenue in Radiolabelled ADME Studies Business (2019-2024)
11.12.5 Nuvisan Recent Development
11.13 Fluorizon
11.13.1 Fluorizon Company Details
11.13.2 Fluorizon Business Overview
11.13.3 Fluorizon Radiolabelled ADME Studies Introduction
11.13.4 Fluorizon Revenue in Radiolabelled ADME Studies Business (2019-2024)
11.13.5 Fluorizon Recent Development
11.14 WuXi AppTec
11.14.1 WuXi AppTec Company Details
11.14.2 WuXi AppTec Business Overview
11.14.3 WuXi AppTec Radiolabelled ADME Studies Introduction
11.14.4 WuXi AppTec Revenue in Radiolabelled ADME Studies Business (2019-2024)
11.14.5 WuXi AppTec Recent Development
11.15 Pharmaron
11.15.1 Pharmaron Company Details
11.15.2 Pharmaron Business Overview
11.15.3 Pharmaron Radiolabelled ADME Studies Introduction
11.15.4 Pharmaron Revenue in Radiolabelled ADME Studies Business (2019-2024)
11.15.5 Pharmaron Recent Development
11.16 InnoStar
11.16.1 InnoStar Company Details
11.16.2 InnoStar Business Overview
11.16.3 InnoStar Radiolabelled ADME Studies Introduction
11.16.4 InnoStar Revenue in Radiolabelled ADME Studies Business (2019-2024)
11.16.5 InnoStar Recent Development
11.17 Medicilon
11.17.1 Medicilon Company Details
11.17.2 Medicilon Business Overview
11.17.3 Medicilon Radiolabelled ADME Studies Introduction
11.17.4 Medicilon Revenue in Radiolabelled ADME Studies Business (2019-2024)
11.17.5 Medicilon Recent Development
11.18 Frontage
11.18.1 Frontage Company Details
11.18.2 Frontage Business Overview
11.18.3 Frontage Radiolabelled ADME Studies Introduction
11.18.4 Frontage Revenue in Radiolabelled ADME Studies Business (2019-2024)
11.18.5 Frontage Recent Development
11.19 Value Pharmaceutical
11.19.1 Value Pharmaceutical Company Details
11.19.2 Value Pharmaceutical Business Overview
11.19.3 Value Pharmaceutical Radiolabelled ADME Studies Introduction
11.19.4 Value Pharmaceutical Revenue in Radiolabelled ADME Studies Business (2019-2024)
11.19.5 Value Pharmaceutical Recent Development
11.20 New Radiomedicine Technology
11.20.1 New Radiomedicine Technology Company Details
11.20.2 New Radiomedicine Technology Business Overview
11.20.3 New Radiomedicine Technology Radiolabelled ADME Studies Introduction
11.20.4 New Radiomedicine Technology Revenue in Radiolabelled ADME Studies Business (2019-2024)
11.20.5 New Radiomedicine Technology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Companies
Charles River
Eurofins Scientific
Evotec AG
LabCorp
SEKISUI Medical
XenoTech (BioIVT)
QPS
Bioduro-Sundia
Quotient Sciences
Chelatec
HMR
Nuvisan
Fluorizon
WuXi AppTec
Pharmaron
Innostar
Medicilon
Frontage
Value Pharmaceutical
New Radiomedicine Technology
List of Tables
 Table 1. Global Radiolabelled ADME Studies Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of C-14
 Table 3. Key Players of H-3
 Table 4. Key Players of Others
 Table 5. Global Radiolabelled ADME Studies Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 6. Global Radiolabelled ADME Studies Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 7. Global Radiolabelled ADME Studies Market Size by Region (2019-2024) & (US$ Million)
 Table 8. Global Radiolabelled ADME Studies Market Share by Region (2019-2024)
 Table 9. Global Radiolabelled ADME Studies Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 10. Global Radiolabelled ADME Studies Market Share by Region (2025-2030)
 Table 11. Radiolabelled ADME Studies Market Trends
 Table 12. Radiolabelled ADME Studies Market Drivers
 Table 13. Radiolabelled ADME Studies Market Challenges
 Table 14. Radiolabelled ADME Studies Market Restraints
 Table 15. Global Radiolabelled ADME Studies Revenue by Players (2019-2024) & (US$ Million)
 Table 16. Global Radiolabelled ADME Studies Market Share by Players (2019-2024)
 Table 17. Global Top Radiolabelled ADME Studies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiolabelled ADME Studies as of 2023)
 Table 18. Ranking of Global Top Radiolabelled ADME Studies Companies by Revenue (US$ Million) in 2023
 Table 19. Global 5 Largest Players Market Share by Radiolabelled ADME Studies Revenue (CR5 and HHI) & (2019-2024)
 Table 20. Global Key Players of Radiolabelled ADME Studies, Headquarters and Area Served
 Table 21. Global Key Players of Radiolabelled ADME Studies, Product and Application
 Table 22. Global Key Players of Radiolabelled ADME Studies, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Radiolabelled ADME Studies Market Size by Type (2019-2024) & (US$ Million)
 Table 25. Global Radiolabelled ADME Studies Revenue Market Share by Type (2019-2024)
 Table 26. Global Radiolabelled ADME Studies Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 27. Global Radiolabelled ADME Studies Revenue Market Share by Type (2025-2030)
 Table 28. Global Radiolabelled ADME Studies Market Size by Application (2019-2024) & (US$ Million)
 Table 29. Global Radiolabelled ADME Studies Revenue Market Share by Application (2019-2024)
 Table 30. Global Radiolabelled ADME Studies Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 31. Global Radiolabelled ADME Studies Revenue Market Share by Application (2025-2030)
 Table 32. North America Radiolabelled ADME Studies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 33. North America Radiolabelled ADME Studies Market Size by Country (2019-2024) & (US$ Million)
 Table 34. North America Radiolabelled ADME Studies Market Size by Country (2025-2030) & (US$ Million)
 Table 35. Europe Radiolabelled ADME Studies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 36. Europe Radiolabelled ADME Studies Market Size by Country (2019-2024) & (US$ Million)
 Table 37. Europe Radiolabelled ADME Studies Market Size by Country (2025-2030) & (US$ Million)
 Table 38. Asia-Pacific Radiolabelled ADME Studies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 39. Asia-Pacific Radiolabelled ADME Studies Market Size by Region (2019-2024) & (US$ Million)
 Table 40. Asia-Pacific Radiolabelled ADME Studies Market Size by Region (2025-2030) & (US$ Million)
 Table 41. Latin America Radiolabelled ADME Studies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 42. Latin America Radiolabelled ADME Studies Market Size by Country (2019-2024) & (US$ Million)
 Table 43. Latin America Radiolabelled ADME Studies Market Size by Country (2025-2030) & (US$ Million)
 Table 44. Middle East & Africa Radiolabelled ADME Studies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 45. Middle East & Africa Radiolabelled ADME Studies Market Size by Country (2019-2024) & (US$ Million)
 Table 46. Middle East & Africa Radiolabelled ADME Studies Market Size by Country (2025-2030) & (US$ Million)
 Table 47. Charles River Company Details
 Table 48. Charles River Business Overview
 Table 49. Charles River Radiolabelled ADME Studies Product
 Table 50. Charles River Revenue in Radiolabelled ADME Studies Business (2019-2024) & (US$ Million)
 Table 51. Charles River Recent Development
 Table 52. Eurofins Scientific Company Details
 Table 53. Eurofins Scientific Business Overview
 Table 54. Eurofins Scientific Radiolabelled ADME Studies Product
 Table 55. Eurofins Scientific Revenue in Radiolabelled ADME Studies Business (2019-2024) & (US$ Million)
 Table 56. Eurofins Scientific Recent Development
 Table 57. Evotec Company Details
 Table 58. Evotec Business Overview
 Table 59. Evotec Radiolabelled ADME Studies Product
 Table 60. Evotec Revenue in Radiolabelled ADME Studies Business (2019-2024) & (US$ Million)
 Table 61. Evotec Recent Development
 Table 62. Labcorp Company Details
 Table 63. Labcorp Business Overview
 Table 64. Labcorp Radiolabelled ADME Studies Product
 Table 65. Labcorp Revenue in Radiolabelled ADME Studies Business (2019-2024) & (US$ Million)
 Table 66. Labcorp Recent Development
 Table 67. Sekisui Medical Company Details
 Table 68. Sekisui Medical Business Overview
 Table 69. Sekisui Medical Radiolabelled ADME Studies Product
 Table 70. Sekisui Medical Revenue in Radiolabelled ADME Studies Business (2019-2024) & (US$ Million)
 Table 71. Sekisui Medical Recent Development
 Table 72. XenoTech (BioIVT) Company Details
 Table 73. XenoTech (BioIVT) Business Overview
 Table 74. XenoTech (BioIVT) Radiolabelled ADME Studies Product
 Table 75. XenoTech (BioIVT) Revenue in Radiolabelled ADME Studies Business (2019-2024) & (US$ Million)
 Table 76. XenoTech (BioIVT) Recent Development
 Table 77. QPS Company Details
 Table 78. QPS Business Overview
 Table 79. QPS Radiolabelled ADME Studies Product
 Table 80. QPS Revenue in Radiolabelled ADME Studies Business (2019-2024) & (US$ Million)
 Table 81. QPS Recent Development
 Table 82. BioDuro-Sundia Company Details
 Table 83. BioDuro-Sundia Business Overview
 Table 84. BioDuro-Sundia Radiolabelled ADME Studies Product
 Table 85. BioDuro-Sundia Revenue in Radiolabelled ADME Studies Business (2019-2024) & (US$ Million)
 Table 86. BioDuro-Sundia Recent Development
 Table 87. Quotient Sciences Company Details
 Table 88. Quotient Sciences Business Overview
 Table 89. Quotient Sciences Radiolabelled ADME Studies Product
 Table 90. Quotient Sciences Revenue in Radiolabelled ADME Studies Business (2019-2024) & (US$ Million)
 Table 91. Quotient Sciences Recent Development
 Table 92. Chelatec Company Details
 Table 93. Chelatec Business Overview
 Table 94. Chelatec Radiolabelled ADME Studies Product
 Table 95. Chelatec Revenue in Radiolabelled ADME Studies Business (2019-2024) & (US$ Million)
 Table 96. Chelatec Recent Development
 Table 97. HMR Company Details
 Table 98. HMR Business Overview
 Table 99. HMR Radiolabelled ADME Studies Product
 Table 100. HMR Revenue in Radiolabelled ADME Studies Business (2019-2024) & (US$ Million)
 Table 101. HMR Recent Development
 Table 102. Nuvisan Company Details
 Table 103. Nuvisan Business Overview
 Table 104. Nuvisan Radiolabelled ADME Studies Product
 Table 105. Nuvisan Revenue in Radiolabelled ADME Studies Business (2019-2024) & (US$ Million)
 Table 106. Nuvisan Recent Development
 Table 107. Fluorizon Company Details
 Table 108. Fluorizon Business Overview
 Table 109. Fluorizon Radiolabelled ADME Studies Product
 Table 110. Fluorizon Revenue in Radiolabelled ADME Studies Business (2019-2024) & (US$ Million)
 Table 111. Fluorizon Recent Development
 Table 112. WuXi AppTec Company Details
 Table 113. WuXi AppTec Business Overview
 Table 114. WuXi AppTec Radiolabelled ADME Studies Product
 Table 115. WuXi AppTec Revenue in Radiolabelled ADME Studies Business (2019-2024) & (US$ Million)
 Table 116. WuXi AppTec Recent Development
 Table 117. Pharmaron Company Details
 Table 118. Pharmaron Business Overview
 Table 119. Pharmaron Radiolabelled ADME Studies Product
 Table 120. Pharmaron Revenue in Radiolabelled ADME Studies Business (2019-2024) & (US$ Million)
 Table 121. Pharmaron Recent Development
 Table 122. InnoStar Company Details
 Table 123. InnoStar Business Overview
 Table 124. InnoStar Radiolabelled ADME Studies Product
 Table 125. InnoStar Revenue in Radiolabelled ADME Studies Business (2019-2024) & (US$ Million)
 Table 126. InnoStar Recent Development
 Table 127. Medicilon Company Details
 Table 128. Medicilon Business Overview
 Table 129. Medicilon Radiolabelled ADME Studies Product
 Table 130. Medicilon Revenue in Radiolabelled ADME Studies Business (2019-2024) & (US$ Million)
 Table 131. Medicilon Recent Development
 Table 132. Frontage Company Details
 Table 133. Frontage Business Overview
 Table 134. Frontage Radiolabelled ADME Studies Product
 Table 135. Frontage Revenue in Radiolabelled ADME Studies Business (2019-2024) & (US$ Million)
 Table 136. Frontage Recent Development
 Table 137. Value Pharmaceutical Company Details
 Table 138. Value Pharmaceutical Business Overview
 Table 139. Value Pharmaceutical Radiolabelled ADME Studies Product
 Table 140. Value Pharmaceutical Revenue in Radiolabelled ADME Studies Business (2019-2024) & (US$ Million)
 Table 141. Value Pharmaceutical Recent Development
 Table 142. New Radiomedicine Technology Company Details
 Table 143. New Radiomedicine Technology Business Overview
 Table 144. New Radiomedicine Technology Radiolabelled ADME Studies Product
 Table 145. New Radiomedicine Technology Revenue in Radiolabelled ADME Studies Business (2019-2024) & (US$ Million)
 Table 146. New Radiomedicine Technology Recent Development
 Table 147. Research Programs/Design for This Report
 Table 148. Key Data Information from Secondary Sources
 Table 149. Key Data Information from Primary Sources
 Table 150. Authors List of This Report


List of Figures
 Figure 1. Radiolabelled ADME Studies Picture
 Figure 2. Global Radiolabelled ADME Studies Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Radiolabelled ADME Studies Market Share by Type: 2023 VS 2030
 Figure 4. C-14 Features
 Figure 5. H-3 Features
 Figure 6. Others Features
 Figure 7. Global Radiolabelled ADME Studies Market Size by Application (2024-2030) & (US$ Million)
 Figure 8. Global Radiolabelled ADME Studies Market Share by Application: 2023 VS 2030
 Figure 9. Biopharmaceutical Companies Case Studies
 Figure 10. Government and Academic Institutes Case Studies
 Figure 11. Others Case Studies
 Figure 12. Radiolabelled ADME Studies Report Years Considered
 Figure 13. Global Radiolabelled ADME Studies Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 14. Global Radiolabelled ADME Studies Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 15. Global Radiolabelled ADME Studies Market Share by Region: 2023 VS 2030
 Figure 16. Global Radiolabelled ADME Studies Market Share by Players in 2023
 Figure 17. Global Top Radiolabelled ADME Studies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiolabelled ADME Studies as of 2023)
 Figure 18. The Top 10 and 5 Players Market Share by Radiolabelled ADME Studies Revenue in 2023
 Figure 19. North America Radiolabelled ADME Studies Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 20. North America Radiolabelled ADME Studies Market Share by Country (2019-2030)
 Figure 21. United States Radiolabelled ADME Studies Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 22. Canada Radiolabelled ADME Studies Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Europe Radiolabelled ADME Studies Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 24. Europe Radiolabelled ADME Studies Market Share by Country (2019-2030)
 Figure 25. Germany Radiolabelled ADME Studies Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 26. France Radiolabelled ADME Studies Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. U.K. Radiolabelled ADME Studies Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. Italy Radiolabelled ADME Studies Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Russia Radiolabelled ADME Studies Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Nordic Countries Radiolabelled ADME Studies Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Asia-Pacific Radiolabelled ADME Studies Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Asia-Pacific Radiolabelled ADME Studies Market Share by Region (2019-2030)
 Figure 33. China Radiolabelled ADME Studies Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. Japan Radiolabelled ADME Studies Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. South Korea Radiolabelled ADME Studies Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. Southeast Asia Radiolabelled ADME Studies Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. India Radiolabelled ADME Studies Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. Australia Radiolabelled ADME Studies Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Latin America Radiolabelled ADME Studies Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. Latin America Radiolabelled ADME Studies Market Share by Country (2019-2030)
 Figure 41. Mexico Radiolabelled ADME Studies Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. Brazil Radiolabelled ADME Studies Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Middle East & Africa Radiolabelled ADME Studies Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Middle East & Africa Radiolabelled ADME Studies Market Share by Country (2019-2030)
 Figure 45. Turkey Radiolabelled ADME Studies Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. Saudi Arabia Radiolabelled ADME Studies Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. UAE Radiolabelled ADME Studies Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 48. Charles River Revenue Growth Rate in Radiolabelled ADME Studies Business (2019-2024)
 Figure 49. Eurofins Scientific Revenue Growth Rate in Radiolabelled ADME Studies Business (2019-2024)
 Figure 50. Evotec Revenue Growth Rate in Radiolabelled ADME Studies Business (2019-2024)
 Figure 51. Labcorp Revenue Growth Rate in Radiolabelled ADME Studies Business (2019-2024)
 Figure 52. Sekisui Medical Revenue Growth Rate in Radiolabelled ADME Studies Business (2019-2024)
 Figure 53. XenoTech (BioIVT) Revenue Growth Rate in Radiolabelled ADME Studies Business (2019-2024)
 Figure 54. QPS Revenue Growth Rate in Radiolabelled ADME Studies Business (2019-2024)
 Figure 55. BioDuro-Sundia Revenue Growth Rate in Radiolabelled ADME Studies Business (2019-2024)
 Figure 56. Quotient Sciences Revenue Growth Rate in Radiolabelled ADME Studies Business (2019-2024)
 Figure 57. Chelatec Revenue Growth Rate in Radiolabelled ADME Studies Business (2019-2024)
 Figure 58. HMR Revenue Growth Rate in Radiolabelled ADME Studies Business (2019-2024)
 Figure 59. Nuvisan Revenue Growth Rate in Radiolabelled ADME Studies Business (2019-2024)
 Figure 60. Fluorizon Revenue Growth Rate in Radiolabelled ADME Studies Business (2019-2024)
 Figure 61. WuXi AppTec Revenue Growth Rate in Radiolabelled ADME Studies Business (2019-2024)
 Figure 62. Pharmaron Revenue Growth Rate in Radiolabelled ADME Studies Business (2019-2024)
 Figure 63. InnoStar Revenue Growth Rate in Radiolabelled ADME Studies Business (2019-2024)
 Figure 64. Medicilon Revenue Growth Rate in Radiolabelled ADME Studies Business (2019-2024)
 Figure 65. Frontage Revenue Growth Rate in Radiolabelled ADME Studies Business (2019-2024)
 Figure 66. Value Pharmaceutical Revenue Growth Rate in Radiolabelled ADME Studies Business (2019-2024)
 Figure 67. New Radiomedicine Technology Revenue Growth Rate in Radiolabelled ADME Studies Business (2019-2024)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global In Vivo and In Vitro ADME Market Research Report 2024
Global Radiolabeling Services Market Research Report 2024
In Vitro ADME Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Radiopharmaceuticals in Nuclear Medicine Market Research Report 2025
Global Radiopharmaceutical Therapy Market Research Report 2025
Global Nuclear Medicine Radiopharmaceuticals Market Research Report 2024
Global Custom Synthesis and Radiolabeling Market Research Report 2024
Global Radiopharmaceutical Market Research Report 2025
Global Drug Metabolism and Pharmacokinetics DMPK Service Market Research Report 2024
In Vitro ADME Services Market
Global SPECT and PET Radiopharmaceuticals Market Research Report 2024
Global SPECT Radiopharmaceuticals Market Research Report 2025
Global Radioisotopes Labeling Services Market Research Report 2024
Global Isotope Labeled Excipient Market Research Report 2024
Global ADME DMPK Studies Market Research Report 2024
Global Diagnostic Radiopharmaceuticals Market Research Report 2024
Global Stable Isotope Labeled Chemicals Market Research Report 2024
Global Radiopharmaceuticals for Diagnosis Market Research Report 2024
Global Radioactive Isotope Labeling Services Market Research Report 2024
Global Targeted Radiopharmaceuticals Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions